Total pelvic exenteration for primary locally advanced and recurrent rectal cancer
Maarten Vermaas(Association of British Orchestras), J. De Wilt, C. Verhoef(Erasmus MC Cancer Institute), WJ Kirkels, Awks Marinelli, Theo Wiggers(University Medical Center Groningen), Ftj Ferenschild, A.M.M. Eggermont(Praxis für Hämatologie und Onkologie), Jjme Nuyttens
Data Archiving and Networked Services (DANS)
January 1, 2000
Cited by 4
Related Papers
Risk factors for anastomotic failure after total mesorectal excision of rectal cancer
|British journal of surgery|2004|665
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
|European Journal of Cancer|2003|240
DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCER
|Unknown|2001|229
Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer
|British journal of surgery|1999|197
Total Pelvic Exenteration for Primary and Recurrent Malignancies
|World Journal of Surgery|2009|193